{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T21:23:48Z","timestamp":1789939428192,"version":"4.0.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T00:00:00Z","timestamp":1688342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2022M3A9G8082639"],"award-info":[{"award-number":["NRF-2022M3A9G8082639"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2022R1A2C2007300"],"award-info":[{"award-number":["NRF-2022R1A2C2007300"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2022R1A2C2007300"],"award-info":[{"award-number":["NRF-2022R1A2C2007300"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2022M3A9G8082639"],"award-info":[{"award-number":["NRF-2022M3A9G8082639"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2022R1A2C2007300"],"award-info":[{"award-number":["NRF-2022R1A2C2007300"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2022M3A9G8082639"],"award-info":[{"award-number":["NRF-2022M3A9G8082639"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Nonalcoholic fatty liver disease (NAFLD) occurs due to the accumulation of fat in the liver, leading to fatal liver diseases such as nonalcoholic steatohepatitis (NASH) and cirrhosis. Elucidation of the molecular mechanisms underlying NAFLD is critical for its prevention and therapy. Here, we observed that deubiquitinase USP15 expression was upregulated in the livers of mice fed a high-fat diet (HFD) and liver biopsies of patients with NAFLD or NASH. USP15 interacts with lipid-accumulating proteins such as FABPs and perilipins to reduce ubiquitination and increase their protein stability. Furthermore, the severity of NAFLD induced by an HFD and NASH induced by a fructose\/palmitate\/cholesterol\/trans-fat (FPC) diet was significantly ameliorated in hepatocyte-specific\n                    <jats:italic>USP15<\/jats:italic>\n                    knockout mice. Thus, our findings reveal an unrecognized function of USP15 in the lipid accumulation of livers, which exacerbates NAFLD to NASH by overriding nutrients and inducing inflammation. Therefore, targeting USP15 can be used in the prevention and treatment of NAFLD and NASH.\n                  <\/jats:p>","DOI":"10.1038\/s12276-023-01036-7","type":"journal-article","created":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T21:01:27Z","timestamp":1688331687000},"page":"1520-1530","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis"],"prefix":"10.1038","volume":"55","author":[{"given":"Jung-Hwan","family":"Baek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Sup","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Ryeon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Seon","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan-ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai Hoon","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6219-4942","authenticated-orcid":false,"given":"Yong-ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene C.","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Soon","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilseon","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungeun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5041-5982","authenticated-orcid":false,"given":"Joon-Yong","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9867-7321","authenticated-orcid":false,"given":"Kyung-Hee","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,3]]},"reference":[{"key":"1036_CR1","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne, C. D. & Targher, G. NAFLD: a multisystem disease. J. Hepatol. 62, S47\u2013S64 (2015).","journal-title":"J. Hepatol."},{"key":"1036_CR2","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1136\/flgastro-2019-101235","volume":"10","author":"CJ Danford","year":"2019","unstructured":"Danford, C. J. & Lai, M. NAFLD: a multisystem disease that requires a multidisciplinary approach. Frontline Gastroenterol. 10, 328\u2013329 (2019).","journal-title":"Frontline Gastroenterol"},{"key":"1036_CR3","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1002\/hep4.1519","volume":"4","author":"S Young","year":"2020","unstructured":"Young, S. et al. Prevalence and profile of nonalcoholic fatty liver disease in lean adults: systematic review and meta-analysis. Hepatol. Commun. 4, 953\u2013972 (2020).","journal-title":"Hepatol. Commun."},{"key":"1036_CR4","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1038\/nrgastro.2013.183","volume":"10","author":"GA Michelotti","year":"2013","unstructured":"Michelotti, G. A., Machado, M. V. & Diehl, A. M. NAFLD, NASH and liver cancer. Nat. Rev. Gastroenterol. Hepatol. 10, 656\u2013665 (2013).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1036_CR5","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jhep.2017.09.003","volume":"68","author":"M Eslam","year":"2018","unstructured":"Eslam, M., Valenti, L. & Romeo, S. Genetics and epigenetics of NAFLD and NASH: Clinical impact. J. Hepatol. 68, 268\u2013279 (2018).","journal-title":"J. Hepatol."},{"key":"1036_CR6","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/nrgastro.2016.3","volume":"13","author":"ME Rinella","year":"2016","unstructured":"Rinella, M. E. & Sanyal, A. J. Management of NAFLD: a stage-based approach. Nat. Rev. Gastroenterol. Hepatol. 13, 196\u2013205 (2016).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"1036_CR7","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jhep.2017.10.006","volume":"68","author":"R Younes","year":"2018","unstructured":"Younes, R. & Bugianesi, E. Should we undertake surveillance for HCC in patients with NAFLD. J. Hepatol. 68, 326\u2013334 (2018).","journal-title":"J. Hepatol."},{"key":"1036_CR8","doi-asserted-by":"publisher","first-page":"e000139","DOI":"10.1136\/bmjgast-2017-000139","volume":"4","author":"S Kenneally","year":"2017","unstructured":"Kenneally, S., Sier, J. H. & Moore, J. B. Efficacy of dietary and physical activity intervention in non-alcoholic fatty liver disease: a systematic review. BMJ Open Gastroenterol. 4, e000139 (2017).","journal-title":"BMJ Open Gastroenterol"},{"key":"1036_CR9","doi-asserted-by":"publisher","first-page":"100669","DOI":"10.1016\/j.aohep.2022.100669","volume":"27","author":"Z Chen","year":"2022","unstructured":"Chen, Z. et al. Ubiquitin-specific protease 1 acts as an oncogene and promotes lenvatinib efficacy in hepatocellular carcinoma by stabilizing c-kit. Ann. Hepatol. 27, 100669 (2022).","journal-title":"Ann. Hepatol."},{"key":"1036_CR10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.dld.2021.02.025","volume":"54","author":"Z Du","year":"2022","unstructured":"Du, Z., Wu, T., Liu, L., Luo, B. & Wei, C. Ubiquitin specific peptidase 1 promotes hepatic fibrosis through positive regulation of CXCL1 by deubiquitinating SNAIL. Dig. Liver Dis. 54, 91\u2013102 (2022).","journal-title":"Dig. Liver Dis."},{"key":"1036_CR11","doi-asserted-by":"publisher","unstructured":"Kamoshita, K. et al. Insulin suppresses ubiquitination via the deubiquitinating enzyme USP14, independent of proteasome activity in H4IIEC3 hepatocytes. J. Pharmacol. Exp. Ther. https:\/\/doi.org\/10.1124\/jpet.122.001088 (2022).","DOI":"10.1124\/jpet.122.001088"},{"key":"1036_CR12","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1038\/nm.3739","volume":"20","author":"D Popovic","year":"2014","unstructured":"Popovic, D., Vucic, D. & Dikic, I. Ubiquitination in disease pathogenesis and treatment. Nat. Med. 20, 1242\u20131253 (2014).","journal-title":"Nat. Med."},{"key":"1036_CR13","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/s41580-019-0099-1","volume":"20","author":"MJ Clague","year":"2019","unstructured":"Clague, M. J., Urbe, S. & Komander, D. Breaking the chains: deubiquitylating enzyme specificity begets function. Nat. Rev. Mol. Cell Biol. 20, 338\u2013352 (2019).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1036_CR14","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nm.4461","volume":"24","author":"YX Ji","year":"2018","unstructured":"Ji, Y. X. et al. The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis. Nat. Med. 24, 213\u2013223 (2018).","journal-title":"Nat. Med."},{"key":"1036_CR15","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1002\/hep.30062","volume":"68","author":"P Luo","year":"2018","unstructured":"Luo, P. et al. Ubiquitin-specific peptidase 10 (USP10) inhibits hepatic steatosis, insulin resistance, and inflammation through Sirt6. Hepatology 68, 1786\u20131803 (2018).","journal-title":"Hepatology"},{"key":"1036_CR16","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.2337\/db16-0506","volume":"65","author":"M Ghosh","year":"2016","unstructured":"Ghosh, M. et al. Ubiquitin ligase COP1 controls hepatic fat metabolism by targeting ATGL for degradation. Diabetes 65, 3561\u20133572 (2016).","journal-title":"Diabetes"},{"key":"1036_CR17","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/nm.4453","volume":"24","author":"P Zhang","year":"2018","unstructured":"Zhang, P. et al. The deubiquitinating enzyme TNFAIP3 mediates inactivation of hepatic ASK1 and ameliorates nonalcoholic steatohepatitis. Nat. Med. 24, 84\u201394 (2018).","journal-title":"Nat. Med."},{"key":"1036_CR18","doi-asserted-by":"publisher","unstructured":"Eichhorn, P. J., Rodon, L., Gonzalez-Junca, A., Baselga, J. & Seoane, J. USP15 stabilizes the TGF-beta receptor I and promotes oncogenesis through the activation of the TGF-beta signal in glioblastoma. Cancer Res. https:\/\/doi.org\/10.1158\/1538-7445.Am2012-Lb-31 (2012).","DOI":"10.1158\/1538-7445.Am2012-Lb-31"},{"key":"1036_CR19","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.1111\/febs.15202","volume":"287","author":"QQ Zhou","year":"2020","unstructured":"Zhou, Q. Q. et al. USP15 potentiates NF-kappa B activation by differentially stabilizing TAB2 and TAB3. FEBS J. 287, 3165\u20133183 (2020).","journal-title":"FEBS J."},{"key":"1036_CR20","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.molcel.2013.04.022","volume":"51","author":"NF Villeneuve","year":"2013","unstructured":"Villeneuve, N. F. et al. USP15 negatively regulates Nr12 through deubiquitination of Keap1. Mol. Cell 51, 68\u201379 (2013).","journal-title":"Mol. Cell"},{"key":"1036_CR21","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/ni.2885","volume":"15","author":"Q Zou","year":"2014","unstructured":"Zou, Q. et al. USP15 stabilizes MDM2 to mediate cancer-cell survival and inhibit antitumor T cell responses. Nat. Immunol. 15, 562\u2013570 (2014).","journal-title":"Nat. Immunol."},{"key":"1036_CR22","doi-asserted-by":"publisher","unstructured":"Kusakabe, S. et al. USP15 participates in hepatitis C virus propagation through regulation of viral RNA translation and lipid droplet formation. J. Virol. https:\/\/doi.org\/10.1128\/JVI.01708-18 (2019).","DOI":"10.1128\/JVI.01708-18"},{"key":"1036_CR23","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1016\/j.cmet.2022.10.007","volume":"34","author":"D Cheng","year":"2022","unstructured":"Cheng, D. et al. MGAT2 inhibitor decreases liver fibrosis and inflammation in murine NASH models and reduces body weight in human adults with obesity. Cell Metab. 34, 1732\u20131748.e1735 (2022).","journal-title":"Cell Metab."},{"key":"1036_CR24","doi-asserted-by":"publisher","unstructured":"Knorr, J. et al. Interleukin-18 signaling promotes activation of hepatic stellate cells in mouse liver fibrosis. Hepatology https:\/\/doi.org\/10.1002\/hep.32776 (2022).","DOI":"10.1002\/hep.32776"},{"key":"1036_CR25","first-page":"5","volume":"51","author":"NJ Kim","year":"2019","unstructured":"Kim, N. J. et al. A PDE1 inhibitor reduces adipogenesis in mice via regulation of lipolysis and adipogenic cell signaling. Exp. Mol. Med. 51, 5 (2019).","journal-title":"Exp. Mol. Med."},{"key":"1036_CR26","doi-asserted-by":"publisher","first-page":"566","DOI":"10.5483\/BMBRep.2017.50.11.031","volume":"50","author":"JH Baek","year":"2017","unstructured":"Baek, J. H., Kim, N. J., Song, J. K. & Chun, K. H. Kahweol inhibits lipid accumulation and induces glucose-uptake through activation of AMP-activated protein kinase (AMPK). BMB Rep. 50, 566\u2013571 (2017).","journal-title":"BMB Rep."},{"key":"1036_CR27","doi-asserted-by":"publisher","first-page":"246","DOI":"10.5483\/BMBRep.2022-0211","volume":"56","author":"MS Hwang","year":"2023","unstructured":"Hwang, M. S., Baek, J. H., Song, J. K., Lee, I. H. & Chun, K. H. Tschimganidine reduces lipid accumulation through AMPK activation and alleviates high-fat diet-induced metabolic diseases. BMB Rep. 56, 246\u2013251 (2023).","journal-title":"BMB Rep."},{"key":"1036_CR28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41419-020-03367-z","volume":"12","author":"JH Baek","year":"2021","unstructured":"Baek, J. H., Kim, D. H., Lee, J., Kim, S. J. & Chun, K. H. Galectin-1 accelerates high-fat diet-induced obesity by activation of peroxisome proliferator-activated receptor gamma (PPAR\u03b3) in mice. Cell Death Dis. 12, 66 (2021).","journal-title":"Cell Death Dis."},{"key":"1036_CR29","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s12276-020-0379-z","volume":"52","author":"JH Lee","year":"2020","unstructured":"Lee, J. H. et al. Isocitrate dehydrogenase 2 protects mice from high-fat diet-induced metabolic stress by limiting oxidative damage to the mitochondria from brown adipose tissue. Exp. Mol. Med. 52, 238\u2013252 (2020).","journal-title":"Exp. Mol. Med."},{"key":"1036_CR30","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1053\/j.gastro.2009.09.061","volume":"138","author":"SJ Kim","year":"2010","unstructured":"Kim, S. J. et al. Galectin-3 increases gastric cancer cell motility by up-regulating fascin-1 expression. Gastroenterology 138, 1035\u20131045 (2010).","journal-title":"Gastroenterology"},{"key":"1036_CR31","doi-asserted-by":"publisher","unstructured":"Cho, Y. et al. Post-translational modification of OCT4 in breast cancer tumorigenesis. Cell Death Differ. https:\/\/doi.org\/10.1038\/s41418-018-0079-6 (2018).","DOI":"10.1038\/s41418-018-0079-6"},{"key":"1036_CR32","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.molcel.2016.02.032","volume":"61","author":"TV Nguyen","year":"2016","unstructured":"Nguyen, T. V. et al. Glutamine triggers acetylation-dependent degradation of glutamine synthetase via the thalidomide receptor cereblon. Mol. Cell 61, 809\u2013820 (2016).","journal-title":"Mol. Cell"},{"key":"1036_CR33","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.1073\/pnas.1700949114","volume":"114","author":"TV Nguyen","year":"2017","unstructured":"Nguyen, T. V. et al. p97\/VCP promotes degradation of CRBN substrate glutamine synthetase and neosubstrates. Proc. Natl Acad. Sci. USA 114, 3565\u20133571 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1036_CR34","doi-asserted-by":"publisher","unstructured":"Nguyen, T. V. USP15 antagonizes CRL4(CRBN)-mediated ubiquitylation of glutamine synthetase and neosubstrates. Proc. Natl Acad. Sci. USA https:\/\/doi.org\/10.1073\/pnas.2111391118 (2021).","DOI":"10.1073\/pnas.2111391118"},{"key":"1036_CR35","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1210\/en.2014-1374","volume":"156","author":"JH Baek","year":"2015","unstructured":"Baek, J. H. et al. Galectin-3 activates PPARgamma and supports white adipose tissue formation and high-fat diet-induced obesity. Endocrinology 156, 147\u2013156 (2015).","journal-title":"Endocrinology"},{"key":"1036_CR36","doi-asserted-by":"publisher","first-page":"100086","DOI":"10.1016\/j.xpro.2020.100086","volume":"1","author":"M Charni-Natan","year":"2020","unstructured":"Charni-Natan, M. & Goldstein, I. Protocol for primary mouse hepatocyte isolation. STAR Protoc. 1, 100086 (2020).","journal-title":"STAR Protoc."},{"key":"1036_CR37","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner, D. E. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313\u20131321 (2005).","journal-title":"Hepatology"},{"key":"1036_CR38","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/onc.2015.80","volume":"35","author":"SJ Kim","year":"2016","unstructured":"Kim, S. J. et al. Activation of nuclear PTEN by inhibition of Notch signaling induces G2\/M cell cycle arrest in gastric cancer. Oncogene 35, 251\u2013260 (2016).","journal-title":"Oncogene"},{"key":"1036_CR39","doi-asserted-by":"publisher","unstructured":"Oligschlaeger, Y. & Shiri-Sverdlov, R. NAFLD preclinical models: more than a handful, less of a concern? Biomedicines https:\/\/doi.org\/10.3390\/biomedicines8020028 (2020).","DOI":"10.3390\/biomedicines8020028"},{"key":"1036_CR40","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1194\/jlr.M039453","volume":"55","author":"JL Chen","year":"2014","unstructured":"Chen, J. L., Lu, X. J., Zou, K. L. & Ye, K. Kruppel-like factor 2 promotes liver steatosis through upregulation of CD36. J. Lipid Res. 55, 32\u201340 (2014).","journal-title":"J. Lipid Res."},{"key":"1036_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-31953-x","volume":"8","author":"JH Kim","year":"2018","unstructured":"Kim, J. H., Jung, D. Y., Nagappan, A. & Jung, M. H. Histone H3K9 demethylase JMJD2B induces hepatic steatosis through upregulation of PPARgamma2. Sci. Rep. 8, 13734 (2018).","journal-title":"Sci. Rep."},{"key":"1036_CR42","doi-asserted-by":"publisher","first-page":"13656","DOI":"10.1073\/pnas.1203218109","volume":"109","author":"YJ Lee","year":"2012","unstructured":"Lee, Y. J. et al. Nuclear receptor PPARgamma-regulated monoacylglycerol O-acyltransferase 1 (MGAT1) expression is responsible for the lipid accumulation in diet-induced hepatic steatosis. Proc. Natl Acad. Sci. USA 109, 13656\u201313661 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1036_CR43","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.cmet.2016.09.016","volume":"24","author":"X Wang","year":"2016","unstructured":"Wang, X. et al. Hepatocyte TAZ\/WWTR1 promotes inflammation and fibrosis in nonalcoholic steatohepatitis. Cell Metab. 24, 848\u2013862 (2016).","journal-title":"Cell Metab."},{"key":"1036_CR44","first-page":"813","volume":"12","author":"YC Hsieh","year":"2021","unstructured":"Hsieh, Y. C. et al. (Pro)renin receptor knockdown attenuates liver fibrosis through inactivation ERK\/TGF-beta 1\/SMAD3 pathway. Cell Mol. Gastroenter. 12, 813\u2013838 (2021).","journal-title":"Cell Mol. Gastroenter."},{"key":"1036_CR45","doi-asserted-by":"publisher","first-page":"6651839","DOI":"10.1155\/2021\/6651839","volume":"2021","author":"J Ji","year":"2021","unstructured":"Ji, J. et al. Apigenin alleviates liver fibrosis by inhibiting hepatic stellate cell activation and autophagy via TGF-beta 1\/Smad3 and p38\/PPAR alpha pathways. PPAR Res. 2021, 6651839 (2021).","journal-title":"PPAR Res."},{"key":"1036_CR46","first-page":"341","volume":"10","author":"XL Zhong","year":"2020","unstructured":"Zhong, X. L. et al. SIRT6 protects against liver fibrosis by deacetylation and suppression of SMAD3 in hepatic stellate cells. Cell Mol. Gastroenter. 10, 341\u2013364 (2020).","journal-title":"Cell Mol. Gastroenter."},{"key":"1036_CR47","doi-asserted-by":"publisher","first-page":"9090","DOI":"10.3390\/ijms21239090","volume":"21","author":"R Mirzayans","year":"2020","unstructured":"Mirzayans, R. & Murray, D. Do TUNEL and other apoptosis assays detect cell death in preclinical studies? Int. J. Mol. Sci. 21, 9090 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"1036_CR48","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1002\/hep.29375","volume":"66","author":"S An","year":"2017","unstructured":"An, S. et al. USP18 protects against hepatic steatosis and insulin resistance through its deubiquitinating activity. Hepatology 66, 1866\u20131884 (2017).","journal-title":"Hepatology"},{"key":"1036_CR49","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/hep.26698","volume":"59","author":"L Yang","year":"2014","unstructured":"Yang, L. et al. Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice. Hepatology 59, 483\u2013495 (2014).","journal-title":"Hepatology"},{"key":"1036_CR50","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/hep.25711","volume":"56","author":"Y Sunami","year":"2012","unstructured":"Sunami, Y. et al. Hepatic activation of IKK\/NFkappaB signaling induces liver fibrosis via macrophage-mediated chronic inflammation. Hepatology 56, 1117\u20131128 (2012).","journal-title":"Hepatology"},{"key":"1036_CR51","first-page":"23","volume":"8","author":"M Furuhashi","year":"2014","unstructured":"Furuhashi, M., Saitoh, S., Shimamoto, K. & Miura, T. Fatty acid-binding protein 4 (FABP4): pathophysiological insights and potent clinical biomarker of metabolic and cardiovascular diseases. Clin. Med. Insights Cardiol. 8, 23\u201333 (2014).","journal-title":"Clin. Med. Insights Cardiol."},{"key":"1036_CR52","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/2211-5463.12240","volume":"7","author":"T Mukai","year":"2017","unstructured":"Mukai, T., Egawa, M., Takeuchi, T., Yamashita, H. & Kusudo, T. Silencing of FABP1 ameliorates hepatic steatosis, inflammation, and oxidative stress in mice with nonalcoholic fatty liver disease. FEBS Open Bio 7, 1009\u20131016 (2017).","journal-title":"FEBS Open Bio"},{"key":"1036_CR53","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1210\/endo.141.9.7637","volume":"141","author":"KT Uysal","year":"2000","unstructured":"Uysal, K. T., Scheja, L., Wiesbrock, S. M., Bonner-Weir, S. & Hotamisligil, G. S. Improved glucose and lipid metabolism in genetically obese mice lacking aP2. Endocrinology 141, 3388\u20133396 (2000).","journal-title":"Endocrinology"},{"key":"1036_CR54","doi-asserted-by":"publisher","first-page":"13974","DOI":"10.1074\/jbc.RA118.003541","volume":"293","author":"JH Sohn","year":"2018","unstructured":"Sohn, J. H. et al. Perilipin 1 (Plin1) deficiency promotes inflammatory responses in lean adipose tissue through lipid dysregulation. J. Biol. Chem. 293, 13974\u201313988 (2018).","journal-title":"J. Biol. Chem."},{"key":"1036_CR55","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1113\/JP277140","volume":"597","author":"DJ Orlicky","year":"2019","unstructured":"Orlicky, D. J. et al. Perilipin-2 promotes obesity and progressive fatty liver disease in mice through mechanistically distinct hepatocyte and extra-hepatocyte actions. J. Physiol. 597, 1565\u20131584 (2019).","journal-title":"J. Physiol."},{"key":"1036_CR56","doi-asserted-by":"publisher","first-page":"G726","DOI":"10.1152\/ajpgi.00436.2015","volume":"310","author":"CP Najt","year":"2016","unstructured":"Najt, C. P. et al. Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis. Am. J. Physiol. Gastrointest. Liver Physiol. 310, G726\u2013G738 (2016).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"1036_CR57","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1002\/hep.21752","volume":"46","author":"S Joshi-Barve","year":"2007","unstructured":"Joshi-Barve, S. et al. Palmitic acid induces production of proinflammatory cytokine interleukin-8 from hepatocytes. Hepatology 46, 823\u2013830 (2007).","journal-title":"Hepatology"},{"key":"1036_CR58","doi-asserted-by":"publisher","first-page":"42774","DOI":"10.1074\/jbc.M306022200","volume":"278","author":"L Vergnes","year":"2003","unstructured":"Vergnes, L., Phan, J., Strauss, M., Tafuri, S. & Reue, K. Cholesterol and cholate components of an atherogenic diet induce distinct stages of hepatic inflammatory gene expression. J. Biol. Chem. 278, 42774\u201342784 (2003).","journal-title":"J. Biol. Chem."}],"updated-by":[{"DOI":"10.1038\/s12276-024-01343-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T00:00:00Z","timestamp":1730073600000}}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-023-01036-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-023-01036-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-023-01036-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T05:12:03Z","timestamp":1730178723000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-023-01036-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,3]]},"references-count":58,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["1036"],"URL":"https:\/\/doi.org\/10.1038\/s12276-023-01036-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-1826647\/v1","asserted-by":"object"}]},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,3]]},"assertion":[{"value":"5 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2024","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: After online publication of this article, the authors noticed an error in the ACKNOWLEDGEMENTS section. The correct statement of this article should have read as below. \u201cThis study was supported by the Bio & Medical Technology Development Program of the National Research Foundation of Korea (NRF) funded by the Korean government (NRF 2021M3A9E4021818 and NRF-2022M3A9G8082639), the NRF grant awarded by the Korean government (NRF-2022R1A2C2007300) and a faculty research grant of Yonsei University College of Medicine (6-2021-0080)\u201d.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2024","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s12276-024-01343-7","URL":"https:\/\/doi.org\/10.1038\/s12276-024-01343-7","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The animal studies were approved by the Yonsei University Health System Institutional Animal Care and Use Committee. Human studies were conducted according to the ethical guidelines of the Declaration of Helsinki, and all individuals gave informed consent. The study protocol was approved by the Institutional Review Board at Severance Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}